132 related articles for article (PubMed ID: 27761802)
1. Contribution of LATS1 and LATS2 promoter methylation in OSCC development.
Ladiz MA; Najafi M; Kordi-Tamandani DM
J Cell Commun Signal; 2017 Mar; 11(1):49-55. PubMed ID: 27761802
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation.
Najafi M; Kordi-Tamandani DM; Arish M
J Ophthalmol; 2016; 2016():5431021. PubMed ID: 26942001
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
[TBL] [Abstract][Full Text] [Related]
5. Promoter Hypermethylation of LATS1 Gene in Oral Squamous Cell Carcinoma (OSCC) among North Indian Population.
Goel H; Mathur R; Syeda S; Shrivastava A; Jha AK
Asian Pac J Cancer Prev; 2021 Mar; 22(3):977-982. PubMed ID: 33773564
[TBL] [Abstract][Full Text] [Related]
6. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
Yue ZW; Liu JZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
[No Abstract] [Full Text] [Related]
7. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
Malik SA; Khan MS; Dar M; Hussain MU; Shah MA; Shafi SM; Mudassar S
Pathol Oncol Res; 2018 Apr; 24(2):207-214. PubMed ID: 28434174
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas.
Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H
J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of the large tumor suppressor genes in Japanese lung cancer.
Sasaki H; Hikosaka Y; Kawano O; Yano M; Fujii Y
Oncol Lett; 2010 Mar; 1(2):303-307. PubMed ID: 22966299
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of promoter region of LATS1--a CDK interacting protein in oral squamous cell carcinomas--a pilot study in India.
Reddy VR; Annamalai T; Narayanan V; Ramanathan A
Asian Pac J Cancer Prev; 2015; 16(4):1599-603. PubMed ID: 25743838
[TBL] [Abstract][Full Text] [Related]
12. Analysis of methylation patterns and expression profiles of p14ARF gene in patients with oral squamous cell carcinoma.
Kordi-Tamandani DM; Moazeni-Roodi A; Rigi Ladez MA; Hashemi M; Birjandian E; Torkamanzehi A
Int J Biol Markers; 2010; 25(2):99-103. PubMed ID: 20586029
[TBL] [Abstract][Full Text] [Related]
13. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
14.
Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
Oncol Lett; 2018 Feb; 15(2):2595-2603. PubMed ID: 29434979
[TBL] [Abstract][Full Text] [Related]
15. A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.
Li ZG; Fu XM; Chai CY; Sun FF; Xiao FF; Huang YX; Yao K; Chen JP; Hou Y
Chin Med J (Engl); 2020 Aug; 133(16):1943-1951. PubMed ID: 32826458
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression of DLEC1 associates with the depth of tumor invasion in oral squamous cell carcinoma.
Chan WH; Chang KP; Yang SW; Yao TC; Ko TY; Lee YS; Tsai CL; Tsai CN
Oral Oncol; 2010 Dec; 46(12):874-9. PubMed ID: 20952247
[TBL] [Abstract][Full Text] [Related]
17. Methylation Assessment of Two
Kheirandish S; Eshghyar N; Yazdani F; Amini Shakib P; Hosseini-Bereshneh A; Nouri Z; Kheiran-Dish A; Karami F
Iran J Public Health; 2020 Oct; 49(10):1947-1953. PubMed ID: 33346226
[TBL] [Abstract][Full Text] [Related]
18. Expression and promoter methylation of Wnt inhibitory factor-1 in the development of oral submucous fibrosis.
Zhou S; Chen L; Mashrah M; Zhu Y; He Z; Hu Y; Xiang T; Yao Z; Guo F; Zhang C
Oncol Rep; 2015 Nov; 34(5):2636-42. PubMed ID: 26352791
[TBL] [Abstract][Full Text] [Related]
19. PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.
Sushma PS; Jamil K; Kumar PU; Satyanarayana U; Ramakrishna M; Triveni B
Tumour Biol; 2016 Jun; 37(6):7625-32. PubMed ID: 26687648
[TBL] [Abstract][Full Text] [Related]
20. Expression of LATS family proteins in ovarian tumors and its significance.
Xu B; Sun D; Wang Z; Weng H; Wu D; Zhang X; Zhou Y; Hu W
Hum Pathol; 2015 Jun; 46(6):858-67. PubMed ID: 25841306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
